Form4insider filings, from the source

SEC Form 4 · accession 0001104659-16-159828

Aegerion Pharmaceuticals, Inc. · AEGR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Anne Vanlent
Director
Period of report
Nov 29, 2016
Accepted (ET)
Nov 30, 2016 · 7:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001338042

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 29, 2016D4,000—D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$37.66Nov 29, 2016D14,700DApr 26, 2016Apr 26, 2023Common Stock14,7000D
Stock Option (Right to Buy)F2$32.55Nov 29, 2016D5,012DJun 26, 2015Jun 26, 2024Common Stock5,0120D
Stock Option (Right to Buy)F2$17.98Nov 29, 2016D18,000DJun 26, 2016Jun 26, 2025Common Stock18,0000D

Explanation of responses